Business
BioMarin to Participate in the Virtual BofA Securities 2020 Napa Biopharma Conference
SAN RAFAEL, Calif., June 23, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Henry Fuchs, M.D., President, Worldwide
About this update from Biomarin Pharmaceutical Inc.
[{"type":"text","content":"SAN RAFAEL, Calif., June 23, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Henry Fuchs, M.D., President, Worldwide Research & Development and Brian Mueller, Acting Chief Financial Officer, will participate in the BofA Securities 2020 Napa Biopharma Conference on June 24, 2020 at 11:30am ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.\n\n \n \n \n \n \n \n\n \nAbout BioMarin\nBioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. \nFor additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.\nContacts:\nInvestors \nMedia \nTraci McCarty \nDebra Charlesworth \nBioMarin Pharmaceutical Inc. \nBioMarin Pharmaceutical Inc. \n(415) 455-7558 \n(415) 455-7451 \n \n\n\n\n View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-virtual-bofa-securities-2020-napa-biopharma-conference-301080544.html\nSOURCE BioMarin Pharmaceutical Inc.","length":6662,"tagName":"div"}]